HIV/AIDS News
Most Popular HIV/AIDS Story
Decision to scrap HIV vax facility stirs controversy
Canadian public health officials and representatives for the Gates Foundation confirmed recently that they are shelving plans for an $88 million facility to manufacture experimental HIV vaccines. The... Read more...
Latest Headlines
- February 24, 2010
- October 15, 2009
- September 23, 2009
- May 20, 2009
- February 4, 2009
- December 4, 2008
- November 12, 2008
- November 6, 2008
- October 9, 2008
- October 6, 2008
- October 2, 2008
- August 14, 2008
- August 7, 2008
- July 31, 2008
- December 20, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
